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Abstract: PRN is the acronym for ‘pro re nata,’ written against prescriptions whose administration should
be based on patients’ needs, rather than at set times. The aim of this systematic review was to explore
safety issues and adverse events arising from PRN prescription and administration. Electronic databases
including Scopus, PubMed [including Medline], Embase, Cinahl, Web of Science and ProQuest were
systematically searched to retrieve articles published from 2005 to 2017. Selection criteria: we included all
randomized controlled trials (RCTs) and studies with comparison groups, comparing PRN prescription
and administration with scheduled administration, where safety issues and adverse events were reported.
The authors independently assessed titles, abstracts and full-texts of retrieved studies based on inclusion
criteria and risk of bias. Results were summarised narratively. The search identified 7699 articles.
Title, abstract and full-text appraisals yielded 5 articles. The included studies were RCTs with one
exception, a pre-test post-test experimental design. Patient populations, interventions and outcomes
varied. Studies compared patient-controlled or routine administration with PRN and one trial assessed the
effect of a practice guideline on implementation of PRN administration. More analgesia was administered
in the patient-controlled than the PRN arms but pain reduction was similar. However, there was little
difference in administration of psychotropic medicines. No differences between patient-controlled and
PRN groups were reported for adverse events. The PRN practice guideline improved PRN patient
education but non-documentation of PRN administration increased. This systematic review suggests that
PRN safety issues and adverse events are an under-researched area of healthcare practice. Variations in
the interventions, outcomes and clinical areas make it difficult to judge the overall quality of the
evidence. Well-designed RCTs are needed to identify any safety issues and adverse events associated
with PRN administration.
Keywords: PRN (pro re nata); medication systems; adverse effects; patient safety; nursing
1. Introduction
PRN prescription and administration is a common practice [1]. PRN is an acronym for ‘pro re
nata,’ authorising administration of medicine when needed, in the opinion of the nurse or patient
administering medications, either at specified times of day or entirely at the nurse’s or patient’s
discretion [2]. Most studies on PRN administration have concerned psychotropic medicines and
investigated impact on symptoms such as sleep disturbances, emotions and psychoses in patients who
have not achieved symptomatic and psychosocial recovery [3]. PRN regimens for disturbed behaviour
and distress [4] or anxiety and agitation [5] are widespread in acute inpatient mental health settings.
PRN prescription and administration of analgesia is also common after surgery [6].
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As a feasible, patient-centred approach, PRN has the potential to encourage patients to participate
in self-care [7] and manage signs and symptoms [8]. PRN prescription may increase efficiency of care [2].
The practice is widespread [9], with 68–83.9% of mental health patients receiving PRN-medication at
least once during their care [5,10,11].
However, limited data are available on adverse events related to PRN administration [8] but
the increased risks of harm due to PRN prescription and administration remains a concern [12,13].
No studies in the nursing literature has compared PRN administration in inpatient versus outpatient
settings but there is a probable risk of non-adherence to medication regimen associated with inefficient
monitoring by healthcare providers in outpatient settings. For instance, Miaskowski et al. [13] reported
that in an oncology outpatient setting the patients’ adherence to their PRN analgesic regimen was only
22.2% to 26.6% during a 5-week period.
1.1. Description of the Intervention
Unscheduled medications fall into the categories of ‘stat’ and ‘PRN.’ Stat medication usually
refers to prescription and administration of a one-off dose in addition to routine/regular medications
prescription. PRN medication is prescribed in advance, with administration as-needed, according to
clinical judgments or under instructions, written or verbal [12,14]. PRN prescription and administration
creates an exceptional circumstance for patient care, allowing frequent or intermittent medicine
use without direct physician supervision [7], typically involving analgesics, laxatives, sedatives,
antiemetics, antipsychotics, anxiolytics and hypnotics [8,9,15]. PRN increases nurses’ involvement in
decision-making and patient care, as it enables nurses to administer medication in a timely manner
without having to call others to write new prescriptions [16]. The reasons for using PRN prescriptions
should be continually monitored to avoid practice errors such as excessive doses, over-use and
polypharmacy and ensure the efficacy of management plans [17]. During PRN prescription and
administration, healthcare providers should record potential adverse drug reactions (ADRs) on a
separate document in the patient’s medical file and share this with prescribers and pharmacists [18,19].
1.2. How the Intervention Might Work
PRN prescription gives healthcare providers latitude to administer medicines rapidly in acute
situations or at the patient’s request [8,20]. If deployed appropriately, PRN administration improves
treatment and relieves symptoms [2,21]. Conversely, abuse or misuse of PRN prescription and
administration negatively influences patient care [2], for example by introducing polypharmacy,
medication errors, adverse reactions, drug interactions and antipsychotic doses above recommended
levels [22]. PRN prescription and administration has the potential to introduce dissonance between
doctors and nurses [2].
1.3. Why It Is Important to Do This Systematic Review
While healthcare professionals agree that PRN prescription and administration is sometimes
necessary for high quality patient care [2], the evaluation of the efficacy and effectiveness of PRN
description and administration is difficult, because PRN administration relies on healthcare providers’
perceptions [10] and their interpretations of prescribers’ intentions [23]. Some interventions have
been suggested to improve PRN prescription and administration, such as separate medication
administration records for PRN and educational programs for healthcare providers [1]. A previous
review indicates that there are few studies to support PRN prescription [24] and current practice is
based on clinical experience and habit rather than high quality evidence [20]. This systematic review
offers a background on PRN prescription, focusing on safety issues.
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2. Aim
The aim of this systematic review was to investigate patient safety and adverse events arising in
conjunction with PRN prescription and administration across healthcare settings.
3. Materials and Methods
3.1. Criteria for Considering Studies for This Systematic Review
We included studies on the prescription and administration of PRN to patients receiving nursing
care. Studies with an emphasis on the efficacy and safety of PRN compared with other types of
medication prescription and administration were included.
3.2. Types of Studies
We sought all relevant randomized controlled trials (RCTs). Due to the low numbers of RCTs of
PRN, we included trials from diverse settings.
3.3. Types of Participants
Any hospital or care home inpatients or outpatients that received PRN prescription and
administration by healthcare providers were considered.
3.4. Types of Interventions
# Any short or long-term medication prescription with administration at the discretion of healthcare
providers (PRN) was considered.
# The ‘as prescribed’ pattern of prescription and administration compared with the PRN pattern.
3.5. Types of Outcome Measures
Only studies reporting adverse events or ‘patient safety’ were included. We considered a range of
outcome measures including patient-reported outcomes and process outcomes.
3.6. Search Methods for Identification of Studies
Electronic databases including Scopus, PubMed [including Medline], Embase, Cinahl, Web of
Science and ProQuest were systematically searched to retrieve articles published between 2005 and
2017, without language restrictions. The search strategy consisted of the keywords below, based on the
authors’ experiences and controlled vocabularies such as the MeSH (medical subject headings):
“Drug-Related Side Effects and Adverse Reactions” or “Adverse Drug Event” or “Adverse Drug
Reaction” or “Drug Side Effects” or “Drug Toxicity” or “Side Effects of Drugs” or “Toxicity, Drug” and
“PRN (pro re nata)” or “as needed” or “as required.”
“Drug-Related Side Effects and Adverse Reactions” or “Adverse Drug Event” or “Adverse Drug
Reaction” or “Drug Side Effects” or “Drug Toxicity” or “Side Effects of Drugs” or “Toxicity, Drug” and
“PRN (pro re nata)” or “as needed” or “as required” and Nurs*.
References in the reviewed articles were backtracked. The indices of well-known journals
publishing in this area were searched.
3.7. Data Collection and Analysis
3.7.1. Selection of Studies
Three authors (M.V., S.A. and S.J.) independently screened titles and abstracts from the retrieved
articles and decided which studies met the inclusion criteria: peer-reviewed RCTs in caring sciences,
focus on PRN and published in online scientific journals. Next, two independent review authors
(M.V. and S.J.) assessed the full-text of selected articles to ensure that they met the above-mentioned
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inclusion criteria using the methodological checklist developed by National Institute for Health and
Care Excellence (NICE) [25]. In case of disagreements, discussions were held to reach consensus.
3.7.2. Data Extraction and Management
Two review authors (M.V. and S.A.) independently extracted the details of articles included
in the review in terms of design, sample, intervention, prescription and administration and
outcome measurement.
3.7.3. Assessment of Bias in Included Studies
Risk of bias is any error or deviation in the design, study process, analysis and reporting of RCTs,
which can cause an underestimation or overestimation of results or inferences [26]. Two authors
(M.V. and S.J.) assessed each selected article using the Cochrane Collaboration’s risk of bias tool [26].
This comprised: ‘selection bias,’ including random sequence generation, allocation concealment;
‘performance bias,’ including blinding of participants and personnel; ‘detection bias,’ including
blinding of outcome assessment and incomplete outcome data assessments; ‘reporting bias,’ including
selective reporting; and ‘other bias,’ such as conflict of interests.
3.7.4. Measures of Treatment Effect and Unit of Analysis
The heterogeneity of the articles precluded a meta-analysis. Results are presented narratively.
3.7.5. Dealing with Missing Data and Assessment of Heterogeneity
Since a meta-analysis could not be performed, no articles were excluded due to missing data and
there was no assessment of heterogeneity.
3.7.6. Data Synthesis
We used a theoretical framework of patient safety to accommodate the studies’ heterogeneity in
terms of designs, participants and interventions.
3.7.7. Quality of the Evidence
The authors employed the ‘grading of recommendations assessment, development and evaluation’
(GRADE) criteria [27,28] to assess the quality of the articles.
3.7.8. Subgroup Analysis, Investigation of Heterogeneity and Sensitivity Analysis
These could not be undertaken, due to inability to pool results.
4. Results
4.1. Description of Studies
Although no language limitations were applied, all relevant articles were in English. Five articles
on the safety and efficacy of PRN prescription and administration are included in this systematic
review. The characteristics of the studies are presented in Table 1.
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Table 1. Summary for the comparisons of findings between the studies.
Title Year ofPublication
Country Aim Participants Methods
Findings for the Main Comparison *
Outcome Impact Agreementbetween Studies
Effect of acetaminophen on
behaviour, well-being and
psychotropic medication use in
nursing home residents with
moderate-to-severe dementia [29]
2005 USA
To evaluate the effect of regularly scheduled
administration of analgesic medication
compared with analgesia ‘as needed’ on
behaviour, emotional well-being and use of
as-needed psychotropic medications in
nursing home residents with
moderate-to-severe dementia.
25 nursing home residents in two
nursing homes, 3 male and
22 females, with a mean age of 85.9
± 7.4
Randomized,
double-blind,
placebo-controlled,
crossover trial.
Psychological
effects
No effect was reported on emotional well-being,
agitation or quality of life. High
Appropriateness of
prescription and
administration
The frequency of psychotropic use by routine and
PRN administration did not differ between study
arms and phases.
High to moderate
Adverse events Some adverse events unrelated to the medicationand drug use pattern were reported. High to moderate
The impact of a good practice
manual on professional practice
associated with psychotropic PRN
in acute mental health wards: an
exploratory study [15]
2008 UK
To assess the effect and acceptability of a
good practice manual on prescribing and
administration practices of PRN
psychotropic medication in acute mental
health wards.
12 physicians, 11 nurses and
35 patients in two acute mental
health wards; gender and age of
participants were not reported.
Pre-post
exploratory
design.
Methods of
sampling and
patient selection
were not reported
Appropriateness of
prescription and
administration
The practice manual influenced the
administration and prescription of PRN
medication. The prescription and administration
of benzodiazepines and antipsychotics were
reduced, whilst the z-drugs were increased.
The maximum doses of antipsychotics
administered using PRN prescriptions were
above safety limits stated in the British National
Formulary. Patient education and provision of
information were increased. Inappropriate or
excessive doses, duplicated co-prescriptions,
administration errors and problematic
documentation were reported in both arms.
High to moderate
The efficacy of intravenous
patient-controlled analgesia after
intracranial surgery of the
posterior fossa: a prospective,
randomized controlled trial [30]
2012 USA
To investigate whether IV patient-controlled
analgesia (PCA) would lead to reductions in
postoperative pain after neurosurgical
procedures involving the posterior fossa
compared with conventional IV
nurse-administered as-needed (PRN)
therapy.
80 patients undergoing elective
surgery in the neurology critical care
unit. The male/female distributions
were 31/21 and 11/20 and the mean
ages were 41.4 ± 11.1 years and 45.4
± 14.6 years for two study arms.
Block randomized
controlled trial
Appropriateness of
prescription and
administration
Patients in the PCA arm received more analgesia
and had more pain relief than the PRN arm High to moderate
Physical effects Patients in the PCA group reported less severepain than the PRN group. High
Adverse events Some adverse events unrelated to the medicationand drug use pattern were reported. High to moderate
Naproxen twice daily versus as
needed (PRN) dosing: efficacy and
tolerability for treatment of acute
ankle sprain, a randomized clinical
trial [31]
2013 Iran
To compare the efficacy and safety of
naproxen 500 mg twice daily (bd) versus
naproxen 500 mg as needed (PRN) for
treatment of ankle sprain.
135 patients with ankle sprain
presenting at the emergency
department of a teaching hospital.
Mean ages were 29.8 ± 10.7 years
and 34.08 ± 15.07 years and gender
distribution was 40 (64.5%) and 33
(55%) for male in the study arms.
Block
randomized,
parallel
group trial
Appropriateness of
prescription and
administration
Adherence to therapeutic regimen was higher in
the bd arm but there was no difference in
analgesic effectiveness.
High to moderate
Physical effects Overall pain reduction was unaffected by modeof prescription. High
Adverse events
PRN regimens appeared safer than the twice
daily regime, possibly due to a significant lower
consumption in the number of tablets.
High to moderate
Comparison of the efficacy and
safety of once-daily dosing and
on-demand use of udenafil for
type 2 diabetic patients with
erectile dysfunction [32]
2015 South
Korea
To compare the efficacy and safety of
once-daily dosing with on-demand use of
udenafil for type 2 diabetic patients with
erectile dysfunction (ED).
141 patients with type 2 diabetes in
seven healthcare centres.The sample
was all male with the mean ages of
54.44 ± 6.00 years and 53.88 ±
6.07 years in the study arms.
Randomized,
open-label,
parallel-group
Physical effects No differences in efficacy or biomarkers ofendothelial function were identified. High
Adverse events
No significant difference was found between
once-daily and PRN dosing with regard to
treatment-related adverse drug reactions.
High to moderate
* Population: Older people, patients, healthcare providers. Interventions: PRN drug use and comparison with other types of drug use patterns.
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4.2. Results of the Search
The search identified 7699 articles that could be potentially included in the review.
From independent appraisal of the titles and abstracts of the articles by two authors (M.V. and
S.J.) deleting duplicates (26 articles) and articles not meeting the inclusion criteria (7650 articles) led
to the selection of 23 articles. Reading the full-text of the articles by two authors of this systematic
review (M.V. and S.J.) for the inclusion criteria and the selection of RCTs over other study designs led
to inclusion of 5 articles. Manual search in the references lists of the included studies identified no
more articles. The process of the search is described using the preferred reporting items for systematic
reviews and meta-analyses (PRISMA) flowchart in Figure 1.
Figure 1. Study flow diagram according to the PRISMA.
4.3. Included Studies
The included studies (n = 5) were published between 2005 and 2015. Two studies [29,30] were
conducted in the USA, one [15] in the UK, one [32] in South Korea and one [31] in Iran. All studies
were small with 25–161 participants recruited.
4.4. Design
Three studies [30–32] were parallel group RCTs. Chibnall et al. [29] was a cross-over RCT.
Baker et al. [15] used a pre-post exploratory design.
4.5. Interventions
Interventions varied. Three studies considered analgesia [29–31], one a phosphodiesterase
inhibitor (udenafil) [32] and one a practice manual [15] (Table 1).
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4.6. Outcomes
The outcomes in the selected articles were diverse:
4.6.1. Psychological Health
Only Chibnall et al. [29] measured behaviour and emotional wellbeing as the primary outcome
and agitation as a secondary outcome.
4.6.2. Appropriateness of Prescription and Administration
In Chibnall et al. [29], routine and PRN psychotropic medication use recorded in nursing home
records was a secondary outcome. Baker et al. [15] evaluated the prescription and administration of
PRN psychotropic medicines by weekly audits of nursing notes and prescription records; consenting
nursing staff were asked why PRN psychotropics were administered and staff were asked to evaluate
the practice manual by postal questionnaire. Morad et al. [30] assessed analgesic administration
records following each pain assessment. Hajimaghsoudi et al. [31] assessed the adherence to the dosing
schedule based on the number of returned tablets.
4.6.3. Physical Health
Morad et al. [30] measured pain, analgesic use, sedation, vital signs (respiration rate, oxygen
saturation, heart rate, systolic blood pressure). Patients were monitored continuously hourly in the
first 10 h and then every two hours until discharge from the ward or the collection of 16 h of data.
Neurological deterioration was also assessed. Hajimaghsoudi et al. [31] assessed ankle pain and
swelling at rest and full weight bearing at baseline and follow up at day 7 as the primary outcome.
Park et al. [32] gave a primary efficacy end point as changes in a subscore of the International Index of
Erectile Dysfunction questionnaire; vascular endothelial markers and vital signs were assessed before
and after treatment.
4.6.4. Adverse Events
Diverse adverse events were monitored, including:
• The adverse effects of paracetamol [29],
• Medication errors associated with PRN prescription and administration [15],
• Neurologic deterioration, excessive sedation, nausea, vomiting, pruritus, insufficient analgesia,
and/or respiratory insufficiency [30],
• The adverse effects of the medicines, such as gastrointestinal bleeding or upset, as a secondary
outcome [31],
• Safety and ADRs using twelve-lead electrocardiograms at screening, after 8 weeks’ treatment and
during the treatment-free follow up period [32].
4.6.5. Excluded Studies
Eighteen studies were excluded [16,21,23,24,33–46]. Details of the excluded studies are in Table 2.
4.6.6. Risk of Bias in Included Studies
The risk of bias varied between studies (Table 3).
4.6.7. Allocation
There were variations in the processes of random sequence generation and concealment among
the studies (Table 1).
Pharmacy 2018, 6, 95 8 of 18
4.6.8. Blinding
Chibnall et al. [29] was blinded. Hajimaghsoudi et al. [31] stated that blinding of participants was
impossible but investigators were blinded. Park et al. [32] was open-label. Other studies did not report
blinding [15,30].
4.6.9. Incomplete Outcome Data
Attrition is reported in Table 3. Incomplete data documentation might have led to high risk of
attrition bias in the studies by Baker et al. [15] and Hajimaghsoudi et al. [31].
4.6.10. Selective Reporting
All studies followed their protocols and reported their findings accordingly.
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Table 2. Characteristics of excluded studies.
Title Authors Year Country Aim Methods Findings Reason for Exclusion
The traditional method of oral as-needed
pain medication delivery compared to an
oral patient-controlled analgesia device
following total knee arthroplasty [33]
Lambert, T.L.,
Cata, D.M. 2014 USA
To compare postoperative pain
control afforded by usual care—PRN
oral pain medication—with the new
oral patient-controlled analgesia
device.
Quantitative, survey of thirty
patients in each group.
The device offered a significant
improvement: less pain, less
interference with general activity,
mood, sleep and appetite during the
first 2 post-operative days and 24 h
before discharge.
Survey
As required versus fixed schedule
analgesic administration for
postoperative pain in children [34]
Hobson, A.,
Wiffen, P.J.,
Conlon, J.A.
2015 UK
To assess the efficacy of PRN versus
fixed schedule analgesia
administration for the management
of postoperative pain in children
under the age of 16 years.
Systematic review, three RCTs of
246 children aged lower than
16 years.
No conclusions were drawn, due to
limited evidence. Systematic review
Patient controlled opioid analgesia
versus non-patient controlled opioid
analgesia for postoperative pain [35]
McNicol, E.D.,
Ferguson, M.C.,
Hudcova, J.
2015 USA
To assess efficiency and safety of
PCA in comparison with non-patient
controlled analgesia of PRN for
relieving postoperative pain.
Meta-analysis, 1725 participants
in the PCA group and
1687 participants in the
non-patient controlled group.
PCA was associated with
significantly: lower pain scores on
visual analogue scales (VAS), greater
satisfaction with opioids, higher
consumption of opioids and higher
incidence of pruritus.
Meta-analysis
Patient controlled opioid analgesia
versus conventional opioid analgesia for
postoperative pain [36]
Hudcova, J.,
McNicol, E., Quah, C.,
Lau, J., Carr, D.B.
2006 USA
To investigate the efficiency of PCA
in comparison with conventional
analgesia for controlling
postoperative pain.
Meta-analysis, 2023 participants
in the PCA group and
1838 participants in the
non-patient controlled
control group.
PCA afforded better pain control and
patient satisfaction than conventional
opioid analgesia.
Meta-analysis
The effects of as-needed nalmefene on
patient-reported outcomes and quality of
life in relation to a reduction in alcohol
consumption in alcohol-dependent
patients [37]
François, C.,
Rahhali, N., Chalem, Y.,
Sørensen, P.,
Luquiens, A.,
Aubin, H.J.
2015 France
To evaluate the effect of as-needed
nalmefene vs. placebo on
health-related quality of life (HRQoL)
in patients with alcohol dependence.
Quantitative, post hoc subgroup
analysis of 2 RCTs with
667 patients.
The majority of patients with
as-needed nalmefene had significant
improvements in HRQoL drinking
behaviour and total
alcohol consumption.
All arms received a
preparation PRN.
Comparisons were
between nalmefene
and placebo.
Systematic review of the predisposing,
enabling and reinforcing factors which
influence nursing administration of
opioids in the postoperative period [38]
Yin, H.H., Tse, M.M.,
Wong, F.K. 2015 China
To describe factors affecting nurses’
decision-making related to PRN
administration of opioid analgesics
for postoperative pain.
Systematic review of
39 qualitative and
quantitative studies.
Nurses’ knowledge of pain
management and opioid analgesia
was the main perceived barrier to
administration of effective pain relief.
Systematic review
A randomized clinical trial of the efficacy
of a self-care intervention to improve
cancer pain management [39]
Rustøen, T.,
Valeberg, B.T.,
Kolstad, E., Wist, E.,
Paul, S.,
Miaskowski, C.
2014 Norway
To assess the efficacy of the
PRO-SELF Pain Control Program on
pain control and opioid intake in
comparison with usual care among
out-patients with bony metastases.
Quantitative, a clinical trial of
self-care, 87 participants in the
PRO-SELF group and
92 participants in the
control group.
Both groups reported significant
reductions in pain intensity scores
and in hours per day in pain.
Total opioid consumption increased
over time in both groups.
No focus on PRN.
Post-operative pain: the impact of
prescribing patterns on nurses’
administration of analgesia [40]
Simons, J., Moseley, L. 2008 UK
To measure the difference between
prescribed analgesia and
administered analgesia in children
during the first 24 h after surgery.
Quantitative, a retrospective
chart review of 175 children.
Less paracetamol was administered
when prescription was on a
PRN basis.
Retrospective cohort
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Table 2. Cont.
Title Authors Year Country Aim Methods Findings Reason for Exclusion
Pro re nata (as needed) medication in
nursing homes: the longer you stay,
the more you get? [41]
Dörks, M.,
Schmiemann, G.,
Hoffmann, F.
2016 Germany To examine predictors of PRNadministration in nursing homes.
Quantitative, cross-sectional
review of medicines charts of
852 residents in 21 homes.
Most (74.9%) residents were treated
with at least one PRN medication.
Acetaminophen (paracetamol) was
the drug most commonly
administered PRN, prescribed to
33.9% residents. PRN prescription
was predicted by duration of
residence and polypharmacy.
A cross sectional
chart review
Pain medication in German nursing
homes: a whole lot of metamizole [42]
Hoffmann, F.,
Schmiemann, G. 2016 Germany
To assess the use of analgesics,
particularly metamizole (not
available in UK) in nursing homes.
Quantitative, cross-sectional
review of medicines charts of
852 residents in 21 homes.
More than half the residents received
at least one analgesic. The most
frequently prescribed medications
were metamizole and paracetamol,
the latter as PRN. The proportion of
residents receiving metamizole
increased with age. Patient safety
concerns were raised by the authors.
A cross sectional,
retrospective,
chart review
Examining trends in the administration
of “as needed” medications to inpatients
with behavioural and psychological
symptoms of dementia [43]
Neumann, R.D.,
Faris, P., Klassen, R. 2015 Canada
To identify trends in the
administration of PRN medications
to inpatients with dementia.
Quantitative, retrospective
review of medicines charts,
170 inpatients with dementia in
neurology wards.
Younger patients received more PRN
prescriptions. PRN prescriptions
were more common following
evening shift change or during
weekends. Where patients were
receiving regularly scheduled
medication from the same drug class,
there was a risk of double dosing,
exceeding dosage guidelines.
Retrospective
chart review
Effect of hospice nonprofessional
caregiver barriers to pain management
on adherence to analgesic administration
recommendations and patient
outcomes [44]
Mayahara, M.,
Foreman, M.D.,
Wilbur, J., Paice, J.A,
Fogg, L.F.
2015 USA
To assess hospice nonprofessional
caregivers’ adherence to analgesic
administrations and patient
outcomes.
Quantitative, a short-term
longitudinal correlational study
of 46 patient–caregiver dyads.
Higher caregiver adherence to PRN
analgesic regimens was associated
with lower patient pain intensity and
higher patient quality of life.
A longitudinal study
Behavioural and psychological
symptoms of dementia: how long does
every behaviour last and are particular
behaviours associated with PRN
antipsychotic agent use? [45]
Voyer, P., McCusker, J.,
Cole, M.G.,
Monette, J.,
Champoux, N.,
Ciampi, A., Belzile, E.,
Richard, H.
2014 USA
To assess the course of behavioural
and psychological symptoms of
dementia (BPSD) over a period of
6 months.
Quantitative, a secondary
analysis of a prospective
observational cohort study of
146 nursing home residents from
7 homes.
PRN administration of antipsychotic
medication was associated with
nocturnal BPSD and requesting help
unnecessarily. Within 3 months, most
BPSD were resolved by usual care
and use of PRN antipsychotic
medication was not associated with
behaviours that put the residents or
their caregivers at risk.
Prospective cohort
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Table 2. Cont.
Title Authors Year Country Aim Methods Findings Reason for Exclusion
PRN prescribing in psychiatric
inpatients: potential for pharmacokinetic
drug interactions [46]
Davies, S.J.,
Lennard, M.S.,
Ghahramani, P.,
Pratt, P., Robertson, A.,
Potokar, J.
2007 UK
To assess the prevalence of PRN
regimens and the potential
interactions involving PRN
medications in mental health wards.
Quantitative, a cross-sectional
survey of prescription charts of
323 inpatients.
In 2089, 48% of prescription items
were on a PRN basis. One fifth of
patients were prescribed drug
combinations interacting via
CYP2D6 or CYP3A4, with potential
for clinical harm. This included one
or more drugs prescribed on a
PRN basis.
A cross-sectional
review of
medicines charts
Administration of PRN medications and
use of non-pharmacologic interventions
in acute geropsychiatric settings:
implications for practice [24]
Lindsey, P.L.,
Buckwalter, K.C. 2012 USA
To evaluate the effect of PRN
psychotropic medications and
non-pharmacological interventions
to manage psychological symptoms
in older adults.
Quantitative, a retrospective
chart audit of 108 medical records
for patients ≥ 55 years or older
admitted to two inpatient
geropsychiatric units over a
3-month period.
Insufficient documentation was
found regarding PRN
administrations and
non-pharmacological interventions
to identify the best clinical practice.
A retrospective chart
audit and review
Nurses’ opinions on appropriate
administration of PRN range opioid
analgesic orders for acute pain [23]
Gordon, D.B.,
Pellino, T.A.,
Higgins, G.A.,
Pasero, C.,
Murphy-Ende, K.
2008 USA
To investigate nurses’ opinions of the
appropriate implementation of
dose-range orders.
Quantitative, online survey of
602 nurses in a medical centre.
Nurses who attended pain
management courses were more
likely to respond appropriately to
questions on patient management
than those who did not.
A cross-sectional survey
A study of the prescription and
administration of sedative PRN
medication to older adults at a secure
hospital [16]
Haw, C.,
Wolstencroft, L. 2014 UK
To investigate the risks of
polypharmacy, high dose
medications and adverse drug
reactions to sedative
PRN medications.
Quantitative, review of patients’
records of 92 older adults and
242 working age patients.
Lorazepam was the most commonly
administered PRN drug and violence
was the most common reason for
administrating it. Documentation of
adverse drug reactions and patient
outcomes was considered
suboptimal. Older people received
less PRN medication and
lower doses.
A retrospective
record review
Pro re nata medication for psychiatric
inpatients: time to act [21]
Hilton, M.F.,
Whiteford, H.A. 2008 Australia
To evaluate PRN administration of
psychotropic medications in term of
mental health policies, professional
ethics and PRN
administration protocols.
Literature review
Development of best practice
guidelines is an essential need for the
use of PRN administration.
Literature review
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Table 3. The Cochrane Risk of Bias Assessment.
Author (Year)
Selection Bias Performance Bias Detection Bias Attrition Bias Reporting Bias Other Bias
Random Sequence
Generation Allocation Concealment
Blinding of Participants
and Personnel
Blinding of Outcome
Assessment Incomplete Outcome Data Selective Reporting
Chibnall et al. (2005) [29] Unclear Unclear Low Low Low, 2 of 25 participants did notcomplete the RCT Low
Unclear, very small sample
size, 1 care home, support
from the manufacturer of the
medicine investigated.
Baker et al. (2008) [15] High High High, no attempt to blind Unclear Unclear, no information Moderate, no informationon adverse effects High
Morad et al. (2012) [30] Low Unclear High, no information High-patients and recoverystaff were not blinded.
Unclear, 6/34 and 9/34 were
excluded for Protocol violations.
High, per protocol not
intention to treat analysis
Unclear, very small sample
size, single centre
Hajimaghsoudi et al. (2013) [31] Low Unclear, no information High, open label High, open label Unclear, no information Unclear, missing data dueto patient non-compliance Unclear
Park et al. (2015) [32] Unclear Unclear High, open label Unclear Moderate, 10/80 participants lostin each arm. No reasons given.
Low, all adverse events
were reported Unclear
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4.6.11. Other Sources of Bias
Baseline characteristics of participants were similar in all studies. Cross-over design may have
minimized the risk of allocation bias in the study of Chibnall et al. [29].
4.6.12. Effects of Interventions
Psychological Health Outcomes
Chibnall et al. [29] found that during the intervention phase, patients spent more time in media
engagement (p = 0.01), direct social interactions (p = 0.05) and work-like activity (p = 0.06) than during
the placebo phase. They spent less time during the treatment phase engaged in independent self-care
(p = 0.02). Emotional wellbeing, agitation, sleeping and independent walking did not differ between
study phases (p = 0.80). No other studies reported psychological outcomes.
Prescription and Administration of Medicines
In the cross-over trial by Chibnall et al. [29], the presence/absence of psychotropic medication
did not vary with routine use of acetaminophen.
Baker et al. [15] investigated the impact of a manual on prescription and administration of
psychotropics. Over 10 weeks, the patients received 484 doses of psychotropics PRN. Three patients
received more than 50 doses and 7 patients did not receive any PRN medications. The types of drugs
changed significantly during the study: benzodiazepines and antipsychotics were reduced but z-drugs
(zopiclone) increased. Many drugs were administered on their own but 12 different combinations of
drugs were used, mainly haloperidol plus lorazepam. 36.5% of prescribed maximum PRN doses of
antipsychotics were equal to or above the British National Formulary advisory limits. The quality of
nursing notes fell and the non-documentation of PRN administration increased after the introduction
of the manual. There was no documented evidence of side-effect monitoring for any dose of PRN
administered during the study in either arm. The mean prescription quality assessed by separate
eight-point quality rating scales increased but this was not statistically significant. The provision of
information and education to patients recorded on forms provided increased significantly after manual
introduction. Staff found the manual well-organized, helpful and understandable.
Morad et al. [30] explored post-operative analgesia. Nurses permitted patients in the PCA group
to receive IV analgesic therapy for longer periods of time than those in the PRN group. For a given
level of pain, the PCA group used almost twice as much fentanyl as the PRN group, with considerable
inter-patient variability.
Hajimaghsoudi et al. [31] explored naproxen for ankle sprain bd versus PRN. More tablets were
returned unused in the PRN group.
Physical Health Outcomes
Morad et al. [30] found patients in the IV PCA group reported less rest pain but received more
fentanyl, than patients in the PRN group (3.7 vs. 5.2 and p = 0.003 and 54.8 vs. 29.9 g/h and p = 0.002).
Hajimaghsoudi et al. [31] reported that overall pain reduction on weight bearing and at rest was
not significantly different between arms.
Park et al. [32] reported that erectile function was improved in the once-daily and PRN arms after
8 weeks of treatment. No significant differences between the groups were found; mean values for all
biomarkers at baseline and after 8 weeks’ treatment were within normal ranges in both arms.
Adverse Events and Errors
Chibnall et al. [29] reported that 2 out of 25 patients experienced serious adverse effects
not attributed to study medication (paracetamol) including collapse due to cardiac ischemia and
hip fracture.
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Baker et al. [15] reported medication errors, excluding poor quality prescribing, in 23 of 35 patients.
Errors included: failure to stop PRN when a regular dose had been prescribed—one patient received
a 30mg daily dose of olanzapine; same medicine prescribed twice as PRN; omitting to cross off
prescriptions, leading to administration of the same drug from two identical prescriptions—one
patient received two different antipsychotics regularly and was prescribed a further two as PRN.
Administration errors included: administration of doses other than that prescribed (usually lower),
inconsistent documentation, inconsistencies between the treatment protocol and nursing notes.
Morad et al. [30] reported no differences between PCA and PRN groups in terms of sedation,
coma, respiratory rate, systolic blood pressure, heart rate, nausea, vomiting, oxygen saturation or
neurological deterioration.
Hajimaghsoudi et al. [31] found the PRN regimen was safer than the twice daily regime with
lower total drug doses. No serious adverse events were reported.
Park et al. [32] reported that udenafil was well-tolerated in both once-daily and PRN arms and
most adverse events were mild to moderate. The most commonly reported treatment-related ADRs
were flushing and headache. No significant differences were found between arms with regard to
treatment-related ADRs or biomarkers of endothelial function.
5. Discussion
5.1. Summary of Main Results of This Review
The authors aimed to investigate safety issues and adverse events associated with PRN (pro re
nata) prescription and administration in healthcare settings. Few randomized controlled trials compare
PRN medication regimens with regular administration of the same drug [20]. We identified only four
such trials addressing safety and adverse events. Variations in the findings in the current review
allow no firm conclusions but the frequency and duration of analgesic use were higher with PCA
than PRN administration [30]. Pain reduction was similar with routine and PRN prescriptions [31,32].
The introduction of a PRN practice manual reduced antipsychotic prescriptions, as patients were
switched to hypnotics and reporting of patient education increased but nursing notes deteriorated and
reporting of adverse effects remained zero [15].
5.2. Overall Completeness and Applicability of Evidence
The paucity and size of relevant studies, diversity of designs, variations in populations and
multiple interventions highlight the incompleteness of the evidence in this systematic review on
patient safety and adverse events related to PRN administration. More studies are needed to explore
whether PRN prescriptions and the associated transfer of decision-making to nurses or patients and
reduced bureaucracy, affects patients’ well-being and quality of care. The safety of PRN prescriptions
may depend on appropriate education for nurses [23,38,44,46] or patients [39] and new technologies
might improve access to information but we found little evidence for this.
5.3. Quality of the Evidence
Low sample sizes, difficulties with blinding, absence of information on sampling, randomization
and attrition in some trials, variations in the designs, interventions, outcomes and results suggest that
the overall quality of evidence is very low. The issues affecting the quality of the included studies
differed and mainly stemmed from a lack of detail regarding the methods and interventions in the
individual studies. Detailed reporting of the signs and symptoms of ADRs or ‘undesirable effects’ as
listed in manufacturers’ literature [47] is essential to improve the work on the effectiveness of PRN
medication regimens. No studies monitored patients for these safety issues, detracting from the data
and the quality of the research.
Pharmacy 2018, 6, 95 15 of 18
5.4. Potential Biases in the Review Process
We tried to reduce bias during this review by conducting a thorough literature search using
different keywords and databases. The Cochrane Risk of Bias Assessment is provided in Table 3.
5.5. Agreements and Disagreements with Other Studies or Reviews
A previous systematic review [20] of PRN medication regimens for seriously ill people in hospital
reported that no evidence from RCTs supporting PRN administration and current practice is based
on clinical experience rather than evidence. No further reviews were identified for comparison with
our findings.
6. Conclusions
6.1. Implications for Practice
Insufficient evidence for PRN administration and prescription suggests that PRN safety issues
and adverse events are under-recognized. The development and implementation of PRN guidelines
described in one of the studies [15] did little to modify errors or improve clinical outcomes but might be
useful to improve patient education. Nurse managers and policy makers need to establish educational
programs for improving healthcare providers’ knowledge of PRN prescription and administration,
how to monitor it and report ADRs and related safety issues [47].
6.2. Implications for Research
Well-designed RCTs of PRN prescription and administration are needed to explore patient
safety. The efficacy and effectiveness of PRN with other methods of medication administration and
prescription is under-explored but our diverse findings suggest that safety will depend on context, both
clinical area and staff preparation. PRN practice guidelines should be developed and evaluated [21],
with a focus on ADR monitoring, reporting and analysing safety data to increase confidence in this
crucial but under-researched practice.
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